Structure activity optimization of 6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazines as Jak1 kinase inhibitors

Bioorganic & Medicinal Chemistry Letters
2015.0

Abstract

Previous work investigating tricyclic pyrrolopyrazines as kinase cores led to the discovery that 1-cyclohexyl-6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazine (12) had Jak inhibitory activity. Herein we describe our initial efforts to develop orally bioavailable analogs of 12 with improved selectivity of Jak1 over Jak2.

Knowledge Graph

Similar Paper

Structure activity optimization of 6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazines as Jak1 kinase inhibitors
Bioorganic & Medicinal Chemistry Letters 2015.0
Discovery of novel selective Janus kinase 2 (JAK2) inhibitors bearing a 1H-pyrazolo[3,4-d]pyrimidin-4-amino scaffold
Bioorganic & Medicinal Chemistry 2019.0
Discovery of imidazopyrrolopyridines derivatives as novel and selective inhibitors of JAK2
European Journal of Medicinal Chemistry 2021.0
Design, synthesis and structure-activity relationship study of aminopyridine derivatives as novel inhibitors of Janus kinase 2
Bioorganic & Medicinal Chemistry Letters 2019.0
Design, Synthesis, and Antitumor Evaluation of 4-Amino-(1H)-pyrazole Derivatives as JAKs Inhibitors
ACS Medicinal Chemistry Letters 2016.0
Discovery of potent anti-inflammatory 4-(4,5,6,7-tetrahydrofuro[3,2-c]pyridin-2-yl) pyrimidin-2-amines for use as Janus kinase inhibitors
Bioorganic & Medicinal Chemistry 2019.0
Design, synthesis and preliminary biological evaluation of 4-aminopyrazole derivatives as novel and potent JAKs inhibitors
Bioorganic & Medicinal Chemistry 2016.0
Benzimidazole Derivatives as Potent JAK1-Selective Inhibitors
Journal of Medicinal Chemistry 2015.0
Design, synthesis and anti-inflammatory evaluation of novel pyrrolo[2,3-d]pyrimidin derivatives as potent JAK inhibitors
Bioorganic & Medicinal Chemistry 2019.0
New pyrazolo[1,5a]pyrimidines as orally active inhibitors of Lck
Bioorganic & Medicinal Chemistry Letters 2010.0